BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 87,048 Value ($000) $661 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 252,414 Value ($000) $2,262 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 586,206 Value ($000) $4,397 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 529,653 Value ($000) $3,983 Avg Close $7.59 Range $6.85 - $8.44
Q4 2023
Shares 1,971,586 Value ($000) $11,810 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 408,297 Value ($000) $2,891 Avg Close $7.18 Range $6.62 - $7.95
Q3 2022
Shares 1,223,721 Value ($000) $15,419 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 1,194,511 Value ($000) $12,638 Avg Close $10.32 Range $7.61 - $18.00
Q1 2020
Shares 3,005,676 Value ($000) $6,011 Avg Close $2.75 Range $1.58 - $4.35
Q4 2017
Shares 11,091 Value ($000) $54 Avg Close $4.84 Range $4.12 - $5.35
Q3 2017
Shares 53,796 Value ($000) $282 Avg Close $5.12 Range $3.95 - $6.22
Q2 2015
Shares 87,111 Value ($000) $1,301 Avg Close $11.37 Range $8.50 - $16.43